Vitality Watch

Dossier pubmed preclinical 02-nov-2026
Animal model, organoid, or cell-culture result — not yet human

Fatty acid desaturation controls cellular fate decisions between senescence and ferroptosis.

Key claim: Dihomo-gamma-linolenic acid (DGLA) depletion allows damaged cells to persist in senescence, and exogenous DGLA supplementation selectively triggers ferroptotic clearance of senescent cells, improving functional outcomes in aged mice.

Abstract

When subject to damage or stress, cells develop responses in order to maintain tissue homeostasis. Two such responses are ferroptosis and cellular senescence, but how cells decide between these outcomes remains unclear. Here, we show that senescent cells increase import and membrane levels of multiple polyunsaturated fatty acids (PUFAs), but a specific intermediate PUFA, dihomo-gamma-linolenic acid (DGLA, 20:3ω-6), is reduced. Exogenous repletion of DGLA instead results in cell death by ferroptosis. Senescent cells manifest additional features associated with ferroptosis, including labile iron and expression of lipoxygenases as well as low-level membrane peroxidation. Oral DGLA supplementation lowers markers of senescence in aged mice and improves age-related functional outcomes. Finally, obese humans with lowered DGLA desaturation rates have lower markers of adipose tissue senescence. Together, our data implicate shifts in PUFA metabolism as a driver of decisions between senescence and ferroptosis.

Why this matters

This cell and aged-mouse study [animal-model] places fatty-acid metabolism upstream of whether damaged cells persist in senescence or undergo ferroptosis, extending the causal picture beyond senescence entry to metabolic control of cell survival. Reported functional improvements with oral DGLA [animal-model] introduce a ferroptosis-based senolytic candidate, not an established human anti-aging supplement; human efficacy, tissue selectivity, and safety remain unestablished. Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Source

Link

Briefing card

Fatty acid desaturation controls cellular fate decisions between senescence and ferroptosis.
Stage: preclinical · pubmed · 02-nov-2026

If you take DGLA for healthy aging, this study's senescent-cell clearance and functional benefits were demonstrated in aged mice, not people.

Dihomo-gamma-linolenic acid (DGLA) depletion allows damaged cells to persist in senescence, and exogenous DGLA supplementation selectively triggers ferroptotic clearance of senescent cells, improving functional outcomes in aged mice.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.cell.2026.09.036

build build 880 · 2bcef25 · 2026-11-18